Trends and Predictors of 30-Day Readmission Among Patients With Infective Endocarditis in the United States From 2010 to 2014

Pasupula, Deepak Kumar; Bhat, A M; Malleshappa, Sudeep Siddappa; Lotfi, Amir Hossein; Slawsky, Mara; Saba, Samir

doi:10.1016/s0735-1097(19)32585-9

Journal of the American College of Cardiology

2019

DOI: 10.1016/s0735-1097(19)32585-9

|View full text |Cite

Trends and Predictors of 30-Day Readmission Among Patients With Infective Endocarditis in the United States From 2010 to 2014

Deepak Kumar Pasupula

A M Bhat²,

Sudeep Siddappa Malleshappa³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Contributors to Hospitalized Infective Endocarditis Outcomes Among Patients With Substance Use

Kociszewski,

Ezemenaka,

Appel

et al. 2024

J Doct Nurs Pract

View full text Add to dashboard Cite

Background:Patients with substance use (SU) diagnosed with infective endocarditis (IE) have high rates of discharge against medical advice (DAMA) and 30-day readmission.Objective:Evaluate contributors associated with DAMA and 30-day readmission among patients with SU and IE.Methods:This retrospective chart review included patients >18 years, admitted to one hospital in the Northeastern, United States for SU and IE from January 2018 to December 2020. Patient demographic and clinical characteristics and their association with DAMA and 30-day readmission were summarized using descriptive statistics and Logistic Regression.Results:Of the 144 patients, 60.4% used more than one substance, 38.2% experienced DAMA, and 61.1% were readmitted within 30 days. Age (odds ratio [OR], 0.96; 95% confidence interval [CI], 0.92–0.98), Length of stay (LOS) (OR, 0.95; 95% CI, 0.93–0.98), Medicaid (OR, 2.98; 95% CI, 1.45–6.16), Medicare (OR, 0.29; 95% CI, 0.10–0.81), opioid usage (OR, 2.29; 95% CI, 1.01–5.16), and stimulant usage (OR, 2.89; 95% CI, 1.43–5.84) were all significantly associated with DAMA but not with 30-day readmission.Conclusions:Additional investigations of factors associated with DAMA and 30-day readmission are needed to help improve practices and reduce negative outcomes.Implications for Nursing:Multiple factors can affect patient adherence to treatment in this high-risk population. Nursing directly impacts the identification and addressing of unique SU IE patient needs to optimize treatment goals.

show abstract

Contributors to Hospitalized Infective Endocarditis Outcomes Among Patients With Substance Use

Kociszewski,

Ezemenaka,

Appel

et al. 2024

J Doct Nurs Pract

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Trends and Predictors of 30-Day Readmission Among Patients With Infective Endocarditis in the United States From 2010 to 2014

Cited by 1 publication

References 0 publications

Contributors to Hospitalized Infective Endocarditis Outcomes Among Patients With Substance Use

Contributors to Hospitalized Infective Endocarditis Outcomes Among Patients With Substance Use

Contact Info

Product

Resources

About